| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Clinical Investigations [D. L., M. W., W. N. H.] and Epidemiology [L. C., M. R. S., Q. W.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Given the same exposure, DNA adduct profiles can be considered as a phenotypic marker for carcinogen metabolism and DNA repair, which may reflect individual susceptibility to chemical carcinogenesis. Based on this notion, we have established a straightforward assay that measures induced DNA adducts in peripheral lymphocytes exposed in vitro to a model carcinogen, benzo(a)pyrene diol epoxide (BPDE) by 32P-postlabeling. To test the hypothesis that the levels of induced DNA adducts are a predictor for cancer risk, we conducted a pilot study of 21 lung cancer patients and 41 healthy frequency-matched controls. We found that the peripheral lymphocytes of cancer patients tended to accumulate higher levels of BPDE-DNA adducts than controls did (mean ± SE of relative adduct labeling x 107 value; 59.6 ± 12.0 versus 39.4 ± 6.1 for cases and controls, respectively; P = 0.09). Using the tertile relative adduct labeling value of controls (10 adducts/107 nucleotides) as the cutoff point, 18 of 21 cases and 23 of 41 controls distributed above this level (odds ratio, 4.7; 95% confidence interval, 1.218.5). In logistic regression analysis, the level of induced adduct was an independent risk factor (odds ratio, 6.4; 95% confidence interval, 1.329.4) after adjustment for the potential confounding factors, i.e., age, sex, ethnicity, and smoking. Stratified analyses showed that greater differences in DNA adduct levels induced by BPDE between cases and controls were observed in individuals younger than 65 years and in nonsmokers. Despite the small sample size, the significant association between the level of BPDE-induced DNA adducts and risk for lung cancer suggests that this assay is a promising method for further investigations.
1 This investigation was supported in part by an institutional start-up fund grant (to Q.W.) and in part by NIH Grants CA 55769 (to M. R. S.) and CA 68437 (to W. N. H.).
2 To whom requests for reprints may be addressed, at Departments of Clinical Investigation (D. L., Box 19) and Epidemiology (Q. W., Box 189), The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.
Received 5/31/96. Accepted 7/ 3/96.
This article has been cited by other articles:
![]() |
H. Zhao, L.-E Wang, D. Li, R. M. Chamberlain, E. M. Sturgis, and Q. Wei Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis Carcinogenesis, August 1, 2008; 29(8): 1560 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-E Wang, P. Xiong, H. Zhao, M. R. Spitz, E. M. Sturgis, and Q. Wei Chromosome Instability and Risk of Squamous Cell Carcinomas of Head and Neck Cancer Res., June 1, 2008; 68(11): 4479 - 4485. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, Q. Wei, Q. Shi, Z. Guo, Y. Qiao, and M. R. Spitz A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma Carcinogenesis, July 1, 2007; 28(7): 1430 - 1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pavanello, A. Pulliero, E. Siwinska, D. Mielzynska, and E. Clonfero Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers Carcinogenesis, January 1, 2005; 26(1): 169 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ito, K. Matsuo, N. Hamajima, T. Mitsudomi, T. Sugiura, T. Saito, T. Yasue, K.-M. Lee, D. Kang, K.-Y. Yoo, et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk Carcinogenesis, August 1, 2004; 25(8): 1395 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Benhamou, A. Laplanche, B. Guillonneau, A. Mejean, F. Desgrandchamps, C. Schrameck, V. Degieux, and F. Perin DNA adducts in normal bladder tissue and bladder cancer risk Mutagenesis, September 1, 2003; 18(5): 445 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Garry, F. Nesslany, E. M. Aliouat, J.-M. Haguenoer, and D. Marzin Potent genotoxic activity of benzo[a]pyrene coated onto hematite measured by unscheduled DNA synthesis in vivo in the rat Mutagenesis, September 1, 2003; 18(5): 449 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Shields Tobacco Smoking, Harm Reduction, and Biomarkers J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Airoldi, F. Orsi, C. Magagnotti, R. Coda, D. Randone, G. Casetta, M. Peluso, A. Hautefeuille, C. Malaveille, and P. Vineis Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies Carcinogenesis, May 1, 2002; 23(5): 861 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Moorthy, K. P. Miller, W. Jiang, and K. S. Ramos The atherogen 3-methylcholanthrene induces multiple DNA adducts in mouse aortic smooth muscle cells: role of cytochrome P4501B1 Cardiovasc Res, March 1, 2002; 53(4): 1002 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Butkiewicz, M. Rusin, L. Enewold, P. G. Shields, M. Chorazy, and C. C. Harris Genetic polymorphisms in DNA repair genes and risk of lung cancer Carcinogenesis, April 1, 2001; 22(4): 593 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, P. F. Firozi, L.-E Wang, C. H. Bosken, M. R. Spitz, W. K. Hong, and Q. Wei Sensitivity to DNA Damage Induced by Benzo(a)pyrene Diol Epoxide and Risk of Lung Cancer: A Case-Control Analysis Cancer Res., February 1, 2001; 61(4): 1445 - 1450. [Abstract] [Full Text] |
||||
![]() |
Qingyi Wei, Lie Cheng, C. I. Amos, L.-E. Wang, Zhaozheng Guo, W. K. Hong, and M. R. Spitz Repair of Tobacco Carcinogen-Induced DNA Adducts and Lung Cancer Risk: a Molecular Epidemiologic Study J Natl Cancer Inst, November 1, 2000; 92(21): 1764 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Wiencke, S. W. Thurston, K. T. Kelsey, A. Varkonyi, J. C. Wain, E. J. Mark, and D. C. Christiani Early Age at Smoking Initiation and Tobacco Carcinogen DNA Damage in the Lung J Natl Cancer Inst, April 7, 1999; 91(7): 614 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Perera Environment and Cancer: Who Are Susceptible? Science, November 7, 1997; 278(5340): 1068 - 1073. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |